sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_874> bl:category bl:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_874> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/drugbank:DB12455> ;
    a rdf:Statement ;
    rdfs:label "nuzyra is a tetracycline class antibacterial indicated for the treatment of adult patients with the following infections caused by susceptible microorganisms 1 community acquired bacterial pneumonia cabp 1 1 acute bacterial skin and skin structure infections absssi 1 2 to reduce the development of drug resistant bacteria and maintain the effectiveness of nuzyra and other antibacterial drugs nuzyra should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria 1 3 nuzyra is indicated for the treatment of adult patients with community acquired bacterial pneumonia cabp caused by the following susceptible microorganisms streptococcus pneumoniae staphylococcus aureus haemophilus influenzae haemophilus parainfluenzae klebsiella pneumoniae legionella pneumophila mycoplasma pneumoniae and chlamydophila pneumoniae nuzyra is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections absssi caused by the following susceptible microorganisms staphylococcus aureus staphylococcus lugdunensis streptococcus pyogenes streptococcus anginosus s anginosus s intermedius s constellatus enterococcus faecalis enterobacter cloacae klebsiella pneumoniae to reduce the development of drug resistant bacteria and maintain the effectiveness of nuzyra and other antibacterial drugs nuzyra should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy" ;
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    bl:provided_by <https://w3id.org/um/NeuroDKG> ;
    bl:relation schema:TreatmentIndication .
  <https://identifiers.org/drugbank:DB12455> bl:category bl:Drug .
}